Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The roles of integrin αvβ6 in cancer
Jun Niu, Zequn Li
Cancer Letters (2017) Vol. 403, pp. 128-137
Closed Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Exploring the Role of RGD-Recognizing Integrins in Cancer
Markus Nieberler, Ute Reuning, Florian Reichart, et al.
Cancers (2017) Vol. 9, Iss. 9, pp. 116-116
Open Access | Times Cited: 371
N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
Huan Jin, Xiaoling Ying, Biao Que, et al.
EBioMedicine (2019) Vol. 47, pp. 195-207
Open Access | Times Cited: 168
RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field
Beatrice Stefanie Ludwig, Horst Kessler, Susanne Kossatz, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1711-1711
Open Access | Times Cited: 164
Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer
Archis Bagati, Sushil Kumar, Peng Jiang, et al.
Cancer Cell (2020) Vol. 39, Iss. 1, pp. 54-67.e9
Open Access | Times Cited: 148
Designing Cancer Immunotherapies That Engage T Cells and NK Cells
Oleksandr Kyrysyuk, Kai W. Wucherpfennig
Annual Review of Immunology (2022) Vol. 41, Iss. 1, pp. 17-38
Open Access | Times Cited: 113
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies
Fatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Integrin αvβ6: Structure, function and role in health and disease
Leeni Koivisto, Jiarui Bi, Lari Häkkinen, et al.
The International Journal of Biochemistry & Cell Biology (2018) Vol. 99, pp. 186-196
Closed Access | Times Cited: 117
Novel Peptide Therapeutic Approaches for Cancer Treatment
Caroline M. Li, Pouya Haratipour, Robert Lingeman, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2908-2908
Open Access | Times Cited: 102
First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma
Kim S. de Valk, Marion M. Deken, Henricus J.M. Handgraaf, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 15, pp. 3990-3998
Open Access | Times Cited: 77
Multiple roles for basement membrane proteins in cancer progression and EMT
Samarpita Banerjee, Wen‐Cheng Lo, Payel Majumder, et al.
European Journal of Cell Biology (2022) Vol. 101, Iss. 2, pp. 151220-151220
Open Access | Times Cited: 67
Integrins regulate stemness in solid tumor: an emerging therapeutic target
Jiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 64
Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules
Yitian Liu, Yuan Zhang, Yong Ding, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 167, pp. 103502-103502
Closed Access | Times Cited: 62
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
Philipp Busenhart, Ana Montalban‐Arques, Egle Katkeviciutė, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e003465-e003465
Open Access | Times Cited: 41
Potential Efficacy of 68Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma
Subha Shankar Das, Sunita Ahlawat, Parul Thakral, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 8, pp. 733-740
Closed Access | Times Cited: 11
Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications
Ute Reuning, Vincenzo Maria D’Amore, Kairbaan Hodivala‐Dilke, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108193-108193
Closed Access | Times Cited: 1
[68Ga]Ga-Trivehexin PET/CT imaging of integrin-αvβ6 expression in concomitant mucinous lung adenocarcinoma and idiopathic pulmonary fibrosis
Huiqin Wu, Ling Li, Zhiwei Xiao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access | Times Cited: 1
Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma
Sven H. Hausner, Richard J. Bold, Lina Y. Cheuy, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 4, pp. 1206-1215
Open Access | Times Cited: 82
PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the “Cancer Integrin” αvβ6 with Ga-68-Trivehexin
Neil Gerard Quigley, Katja Steiger, Sebastian Hoberück, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 4, pp. 1136-1147
Open Access | Times Cited: 53
The αvβ6 integrin in cancer cell‐derived small extracellular vesicles enhances angiogenesis
Shiv Ram Krishn, Israa Salem, Fabio Quaglia, et al.
Journal of Extracellular Vesicles (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 52
Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature
Mingxin Cao, Enyu Shi, Hanping Wang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4293-4306
Open Access | Times Cited: 35
PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
Biao Zhang, Bingqian Huang, Xiaonan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 21
Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and Prospects
Yanxiang Cheng, Zhen Qu, Jiang Qian, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 21
Cross-Talk between the TGF-β and Cell Adhesion Signaling Pathways in Cancer
Jiahao Liao, Rentang Chen, Bihua Lin, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 7, pp. 1307-1320
Open Access | Times Cited: 8
Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer
Saidu Sani, Melissa Messé, Quentin Fuchs, et al.
ChemBioChem (2020) Vol. 22, Iss. 7, pp. 1151-1160
Open Access | Times Cited: 50
The ITGB6 gene: its role in experimental and clinical biology
Amelia Meecham, John F. Marshall
Gene (2019) Vol. 763, pp. 100023-100023
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top